LPIN1 and breast carcinoma: To identify potential lipin-1 interacting proteins, we first replaced the endogenous lipin-1 with Flag-tagged counterpart in the MDA-MB-231 cell line of breast cancer origin by using the CRISPR/Cas9 technique (Supplementary Fig. 1a, b).